Babar Khan, M., Ruggieri, R., Tran, N., Sarkaria, J., MacDiarmid, J., Brahmbhatt, H., . . . Symons, M. (2019). DDIS-18. NANOCELL-MEDIATED DELIVERY OF MIR-34A COUNTERACTS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA. Neuro Oncol.
Παραπομπή Chicago StyleBabar Khan, Muhammad, Rosamaria Ruggieri, Nhan Tran, Jann Sarkaria, Jennifer MacDiarmid, Himanshu Brahmbhatt, John Boockvar, και Marc Symons. "DDIS-18. NANOCELL-MEDIATED DELIVERY OF MIR-34A COUNTERACTS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA." Neuro Oncol 2019.
Παραπομπή MLABabar Khan, Muhammad, et al. "DDIS-18. NANOCELL-MEDIATED DELIVERY OF MIR-34A COUNTERACTS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA." Neuro Oncol 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.